Form 8-K - Current report:
SEC Accession No. 0001279569-24-001454
Filing Date
2024-12-06
Accepted
2024-12-06 07:00:39
Documents
14
Period of Report
2024-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 25530
2 SEVERANCE PLAN ex991.htm EX-99.1 44398
  Complete submission text file 0001279569-24-001454.txt   257416

Data Files

Seq Description Document Type Size
3 XBRL LABEL FILE epix-20240605_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE epix-20240605_pre.xml EX-101.PRE 22363
5 XBRL SCHEMA FILE epix-20240605.xsd EX-101.SCH 3021
17 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3772
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 241530521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)